Marco Investment Management LLC Pfizer Inc Transaction History

Marco Investment Management LLC

$1.15 Billion
Q3 2024

A detailed history of Marco Investment Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Marco Investment Management LLC holds 148,432 shares of PFE stock, worth $3.92 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

148,432

Previous 143,332 3.56%

Holding current value

$3.92 Million

Previous $4.01 Million 7.11%

% of portfolio

0.37%

Previous 0.37%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$27.7 - $31.39 $141,270 - $160,089	5,100 Added 3.56%	148,432 $4.3 Million
Q2 2024 Aug 07, 2024	BUY	$25.26 - $29.6 $164,745 - $193,051	6,522 Added 4.77%	143,332 $4.01 Million
Q1 2024 May 08, 2024	BUY	$25.89 - $29.73 $27,184 - $31,216	1,050 Added 0.77%	136,810 $3.8 Million
Q4 2023 Feb 05, 2024	SELL	$26.13 - $33.94 $55,082 - $71,545	-2,108 Reduced 1.53%	135,760 $3.91 Million
Q3 2023 Nov 07, 2023	SELL	$32.09 - $37.51 $105,191 - $122,957	-3,278 Reduced 2.32%	137,868 $4.57 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $318,686 - $368,713	-8,823 Reduced 5.88%	141,146 $5.18 Million
Q1 2023 May 11, 2023	SELL	$39.39 - $51.28 $273,721 - $356,344	-6,949 Reduced 4.43%	149,969 $6.12 Million
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $32,815 - $42,837	786 Added 0.5%	156,918 $8.04 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $40,871 - $49,894	-934 Reduced 0.59%	156,132 $6.83 Million
Q2 2022 Aug 05, 2022	BUY	$46.53 - $55.17 $406,765 - $482,296	8,742 Added 5.89%	157,066 $8.24 Million
Q1 2022 May 11, 2022	SELL	$45.75 - $56.69 $63,958 - $79,252	-1,398 Reduced 0.93%	148,324 $7.68 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $17,974 - $26,643	435 Added 0.29%	149,722 $8.84 Million
Q3 2021 Nov 10, 2021	SELL	$39.25 - $50.42 $57,893 - $74,369	-1,475 Reduced 0.98%	149,287 $6.42 Million
Q2 2021 Aug 11, 2021	BUY	$35.91 - $40.68 $176,246 - $199,657	4,908 Added 3.37%	150,762 $5.9 Million
Q1 2021 May 06, 2021	BUY	$33.49 - $37.77 $588,419 - $663,618	17,570 Added 13.7%	145,854 $5.28 Million
Q4 2020 Feb 11, 2021	BUY	$33.47 - $42.56 $144,222 - $183,391	4,309 Added 3.48%	128,284 $4.72 Million
Q3 2020 Oct 27, 2020	BUY	$31.75 - $37.25 $316,071 - $370,823	9,955 Added 8.73%	123,975 $4.55 Million
Q2 2020 Jul 21, 2020	SELL	$30.12 - $36.54 $72,257 - $87,659	-2,399 Reduced 2.06%	114,020 $3.73 Million
Q1 2020 Apr 17, 2020	SELL	$27.03 - $38.62 $65,331 - $93,344	-2,417 Reduced 2.03%	116,419 $3.8 Million
Q4 2019 Feb 11, 2020	SELL	$32.92 - $37.36 $283,309 - $321,520	-8,606 Reduced 6.75%	118,836 $4.66 Million
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $16,699 - $21,654	514 Added 0.4%	127,442 $4.58 Million
Q2 2019 Aug 06, 2019	SELL	$36.98 - $41.52 $25,996 - $29,188	-703 Reduced 0.55%	126,928 $5.5 Million
Q1 2019 May 02, 2019	SELL	$37.5 - $41.2 $305,475 - $335,615	-8,146 Reduced 6.0%	127,631 $5.42 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $394,856 - $450,179	-10,264 Reduced 7.03%	135,777 $5.93 Million
Q3 2018 Nov 09, 2018	SELL	$34.47 - $41.81 $2,137 - $2,592	-62 Reduced 0.04%	146,041 $6.44 Million
Q2 2018 Aug 10, 2018	SELL	$32.98 - $35.16 $257,870 - $274,916	-7,819 Reduced 5.08%	146,103 $5.3 Million
Q1 2018 May 01, 2018	BUY	$31.91 - $37.02 $15,955 - $18,510	500 Added 0.33%	153,922 $5.46 Million
Q4 2017 Feb 15, 2018	SELL	$33.26 - $35.29 $184,759 - $196,035	-5,555 Reduced 3.49%	153,422 $5.56 Million
Q3 2017 Nov 14, 2017	SELL	$31.0 - $34.15 $165,695 - $182,531	-5,345 Reduced 3.25%	158,977 $5.68 Million
Q2 2017 Aug 11, 2017	BUY	N/A	164,322	164,322 $5.52 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marco Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marco Investment Management LLC with notifications on news.

Account

Marco Investment Management LLC Pfizer Inc Transaction History